Cinenses Lung Volume Reduction Reverser System First-in-man Study Treating Patients With Severe Emphysema
- Conditions
- Emphysema
- First Posted Date
- 2018-09-26
- Last Posted Date
- 2021-06-29
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT03685526
- Locations
- 🇩🇪
Thoraxklinik am Universitätsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany
Safety and Efficacy Study of FemFlow Drug-Eluting Peripheral Balloon Catheter
- Conditions
- Femoral Artery StenosisPopliteal Arterial StenosisFemoral Artery OcclusionPopliteal Artery Occlusion
- First Posted Date
- 2018-09-25
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 208
- Registration Number
- NCT03683459
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
🇨🇳Zhongshan Hospital Xiamen University, Xiamen, Fujian, China
🇨🇳The First People's Hospital of Foshan, Foshan, Guangdong, China
Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up Study
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2018-09-12
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 500
- Registration Number
- NCT03666780
- Locations
- 🇨🇳
1001 - HKU Queen Mary Hospital, Hong Kong, China
🇩🇰201 - Aarhus Universitetshospital, Aarhus, Denmark
🇩🇪104 - Charité Campus Benjamin Franklin (CBF), Berlin, Germany
A First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System
- Conditions
- Single Coronary Vessel Disease
- First Posted Date
- 2018-08-06
- Last Posted Date
- 2018-08-06
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT03616132
- Locations
- 🇲🇾
Institut Jantung Negara, Kuala Lumpur, Negeri Selangor, Malaysia
🇲🇾University Malaya Medical Centre, Kuala Lumpur, Negeri Selangor, Malaysia
Safety and Efficacy Study of Absnow Absorbable ASD Closure System For Treating ASD Patients
- Conditions
- Atrial Septal DefectHeart Septal Defects, Atrial
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2018-07-26
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 144
- Registration Number
- NCT03601039
- Locations
- 🇨🇳
Pan Xiangbin, Beijing, Beijing, China
🇨🇳Yi Kaijian, Chongqing, Chongqing, China
🇨🇳Zhang Zhiwei, Guangzhou, Guangdong, China
A First-in-Man Study of IBS
- Conditions
- Single Coronary Vessel Disease
- First Posted Date
- 2018-04-26
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT03509142
- Locations
- 🇨🇳
Beijing Fuwai hospital, Peking, China
Clinical Investigation of the LAmbre Left Atrial Appendage Closure System
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2017-04-20
- Last Posted Date
- 2017-04-21
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 61
- Registration Number
- NCT03122028
Post Market Clinical Follow-up Study of IrisFITTM PFO (Patent Foramen Ovale) Occluder
- Conditions
- Patent Foramen Ovale
- First Posted Date
- 2016-08-30
- Last Posted Date
- 2018-08-09
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 85
- Registration Number
- NCT02882815
- Locations
- 🇩🇪
Cardio Vasculäres Centrum Frankfurt, Frankfurt, Germany
🇩🇪Helmut-G.-Walther-Klinikum, Lichtenfels, Germany
🇮🇪Mater Misericordiae University Hospital, Dublin, Ireland
Lifetech CeraFlex™ Post-Market Surveillance Study
- Conditions
- Atrial Septal DefectPatent Foramen OvalePatent Ductus Arteriosus
- First Posted Date
- 2015-12-03
- Last Posted Date
- 2020-03-13
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT02621528
- Locations
- 🇫🇷
AP Hospital Europeen G Pompidou and Hospital Necker, Paris, France
🇩🇪Deutsches Herzzentrum Berlin, Berlin, Germany
🇩🇪Herzzentrum Leipzig GmbH, Leipzig, Germany
Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2014-01-07
- Last Posted Date
- 2014-03-18
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 154
- Registration Number
- NCT02029014
- Locations
- 🇨🇳
People's Hospital of Wuhan University, Wuhan, Hubei, China